Veronika Rauscher1, Matthias Englbrecht1, Désirée van der Heijde1, Georg Schett1, Axel J Hueber2. 1. From the Department of Internal Medicine 3 and the Institute for Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany; and the Department of Rheumatology, Leiden University Medical Center, Leiden, the Netherlands.V. Rauscher, Medical Student; M. Englbrecht, Dipl.-Psych. Univ.; G. Schett, MD, Professor; A.J. Hueber, MD, PhD, Department of Internal Medicine 3 and Institute for Clinical Immunology, University of Erlangen-Nuremberg; D. van der Heijde, MD, Professor, Department of Rheumatology, Leiden University Medical Center. 2. From the Department of Internal Medicine 3 and the Institute for Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany; and the Department of Rheumatology, Leiden University Medical Center, Leiden, the Netherlands.V. Rauscher, Medical Student; M. Englbrecht, Dipl.-Psych. Univ.; G. Schett, MD, Professor; A.J. Hueber, MD, PhD, Department of Internal Medicine 3 and Institute for Clinical Immunology, University of Erlangen-Nuremberg; D. van der Heijde, MD, Professor, Department of Rheumatology, Leiden University Medical Center. axel.hueber@uk-erlangen.de.
Abstract
OBJECTIVE: To test medication adherence using the Compliance-Questionnaire-Rheumatology (CQR). METHODS: Invitation letter and CQR were sent to 240 patients with rheumatoid arthritis. Followup CQR was sent 3 months later. Adherence was evaluated using CQR 80% cutoff scores. RESULTS: Seventy-eight patients who were being treated with disease-modifying antirheumatic drugs provided full information on the CQR at both points in time. Eleven patients (14.1%) were classified as adherent based on taking compliance (TC), with only 3 patients (3.8%) adherent in regard to correct dosing (CD) [followup: 13 (16.7%) and 3 (3.8%) for TC and CD, respectively]. Nonadherence was not related to disease activity or side effects. CONCLUSION: We demonstrated low adherence, suggesting differences between doctors' records and patients' practice of antirheumatic drug therapy.
OBJECTIVE: To test medication adherence using the Compliance-Questionnaire-Rheumatology (CQR). METHODS: Invitation letter and CQR were sent to 240 patients with rheumatoid arthritis. Followup CQR was sent 3 months later. Adherence was evaluated using CQR 80% cutoff scores. RESULTS: Seventy-eight patients who were being treated with disease-modifying antirheumatic drugs provided full information on the CQR at both points in time. Eleven patients (14.1%) were classified as adherent based on taking compliance (TC), with only 3 patients (3.8%) adherent in regard to correct dosing (CD) [followup: 13 (16.7%) and 3 (3.8%) for TC and CD, respectively]. Nonadherence was not related to disease activity or side effects. CONCLUSION: We demonstrated low adherence, suggesting differences between doctors' records and patients' practice of antirheumatic drug therapy.
Authors: Arnd Kleyer; Laura Beyer; Christoph Simon; Fabian Stemmler; Matthias Englbrecht; Christian Beyer; Jürgen Rech; Bernhard Manger; Gerhard Krönke; Georg Schett; Axel J Hueber Journal: Arthritis Res Ther Date: 2017-02-10 Impact factor: 5.156